ABL Bio-Technologies Ltd.
| BSE: 526955 |
Sector: Health care |
| NSE: N.A. |
ISIN Code: INE707D01016 |
|
BSE
00:00 | 04 Mar
|
ABL Bio-Technologies Ltd
|
|
NSE
05:30 | 01 Jan
|
ABL Bio-Technologies Ltd
|
| OPEN |
2.16 |
| PREVIOUS CLOSE |
2.16 |
| VOLUME |
895 |
| 52-Week high |
2.16 |
| 52-Week low |
0.00 |
| P/E |
|
| Mkt Cap.(Rs cr) |
2 |
| Buy Price |
2.06 |
| Buy Qty |
1200.00 |
| Sell Price |
2.16 |
| Sell Qty |
6650.00 |
| OPEN |
|
| PREVIOUS CLOSE |
|
| VOLUME |
|
| 52-Week high |
0.00 |
| 52-Week low |
0.00 |
| P/E |
|
| Mkt Cap.(Rs cr) |
2 |
| Buy Price |
|
| Buy Qty |
|
| Sell Price |
|
| Sell Qty |
|
| OPEN |
2.16 |
| CLOSE |
2.16 |
| VOLUME |
895 |
| 52-Week high |
2.16 |
| 52-Week low |
0.00 |
| P/E |
|
| Mkt Cap.(Rs cr) |
2 |
| Buy Price |
2.06 |
| Buy Qty |
1200.00 |
| Sell Price |
2.16 |
| Sell Qty |
6650.00 |
| OPEN |
|
| PREVIOUS CLOSE |
|
| VOLUME |
|
| 52-Week high |
0.00 |
| 52-Week low |
0.00 |
| P/E |
|
| Mkt Cap.(Rs cr) |
1.77 |
| Buy Price |
|
| Buy Qty |
|
| Sell Price |
|
| Sell Qty |
|
ABL Bio-Technologies Ltd. (ABLBIOTECH) - Company Information
ABL Bio-Technologies Ltd
ABL Bio Technologies Limited (ABL) is an India-based biotechnology company. The Company operates in three segments: formulation, research and development and the Docosahexaenoic acid (DHA) project. The Company focuses on discovery, collection of microbes, establishment of compound libraries, discovery of drug and nutrition targets and conducting research and converting the strains/compounds in to ...> More
| COMPANY INFORMATION |
| Chairman & Managing Director : |
K O Isaac |
| Director : |
G Subramanian |
| Director : |
V M Sankaran Nampoothiri |
| AUDITOR : |
Pratapkaran Paul & Co |
| IND NAME : |
Pharmaceuticals - Indian - Formulations |
| HOUSE NAME : |
Indian Private |
| Registered office |
| No 1 Wallers Lane 1st Floor, Room 3 Mataji Complex Mount Rd,Chennai,Tamil Nadu-600002 |
| Ph : |
| WEBSITE : http://www.ablbiotechnologies.com |
| E-mail : |
Quick Links for ABL Bio-Technologies:
